Cost of illness associated with influenza in the UK
Trial overview
Incidence of influenza-related events
Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
Number of confirmed influenza infections
Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
Assessment of resource use
Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
Evaluation of patient outcomes, treatments and costs (type and duration)
Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
Cause of deaths
Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
Incidence of influenza-related events in High Risk groups
Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
Incidence of complications and exacerbations
Timeframe: Over the study time period (from January 21st 2001 to March 31st 2009 inclusive)
- Male or female patients coded within the database as having acute respiratory events that could be related to an infection between 2001 and 2009.
- Patients must have a minimum of 14 days observation before and after the index event to permit the capturing of complications attributable to influenza.
- Not Applicable
- Patients must have a minimum of 14 days observation before and after the index event to permit the capturing of complications attributable to influenza.
Male or female patients coded within the database as having acute respiratory events that could be related to an infection between 2001 and 2009.
- Not Applicable
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.